Noveris Health Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYCOF research report →
About the company
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.
- CEO
- Jason Birmingham
- IPO
- 2021
- Employees
- 3
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $117.10M
- P/E
- 9.75
- P/S
- 0.00
- P/B
- -1.42
- EV/EBITDA
- 14.21
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -14.60%
- ROIC
- 47.11%
- Revenue
- $0 · 0.00%
- Net Income
- $2.92M · 192.67%
- EPS
- $2.37 · 4580.15%
- Op Income
- $-549,937
- FCF YoY
- 0.00%
- 52W High
- $2.04
- 52W Low
- $0.03
- 50D MA
- $1.42
- 200D MA
- $0.62
- Beta
- -5.43
- Avg Volume
- 501
Get TickerSpark's AI analysis on MYCOF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MYCOF coverage
Recent articles, reports, and earnings notes.
No research on MYCOF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MYCOF report →Similar companies
Peers in the same neighborhood.